Diabetes-Related Mental Health Impacts and Healthcare Expenditures

The global burden of diabetes extends far beyond metabolic dysfunction to encompass significant mental health challenges and escalating costs to health systems. Psychological comorbidities such as depression, anxiety and diabetes distress are highly prevalent in both type 1 and type 2 populations, often precipitating poorer self-care, suboptimal glycaemic control and increased risk of complications. Biological mechanisms—such as inflammatory pathways and hypothalamic–pituitary–adrenal axis dysregulation—interact with psychosocial stressors related to disease management to reinforce a bidirectional relationship between metabolic and mental health. Patients with coexisting depression routinely demonstrate higher rates of healthcare utilisation, longer hospital stays and elevated direct medical expenditures. Indirect costs, including lost productivity and informal caregiving, further amplify the economic impact. In response, integrated care models, digital health platforms and nurse-led initiatives are being deployed to identify psychological risk early, deliver timely interventions and optimise resource allocation. Recent emphasis on data-driven risk prediction, technology-facilitated collaborative care and robust economic evaluations underscores the urgency of holistic approaches that alleviate mental distress and constrain financial pressures on healthcare infrastructures worldwide.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Diabetes-Related Mental Health Impacts and Healthcare Expenditures publication trend

The graph below shows the total number of articles in diabetes-related mental health impacts and healthcare expenditures across all publications each year (not limited to Nature Index journals).

Technical terms

Comorbid depression: The simultaneous presence of depressive disorder alongside diabetes, which exacerbates health risks and resource use.

Electronic health records (EHRs): Digital repositories of patient medical information used to analyse longitudinal data and predict health outcomes.

Budget impact analysis: An assessment estimating the financial consequences of implementing a healthcare programme within a defined budget.

Incremental cost-effectiveness ratio (ICER): A measure comparing the additional cost per additional unit of health benefit achieved by one intervention over another.

Glycaemic control: The regulation of blood glucose concentrations, often monitored via glycated haemoglobin, to minimise diabetes complications.

References

1. Applying contrastive pre-training for depression and anxiety risk prediction in type 2 diabetes patients based on heterogeneous electronic health records: a primary healthcare case study. Journal of the American Medical Informatics Association (2023).
2. Nurse‐Led Telephone Program for Nonadherent to Treatment Type 2 Diabetics With Comorbid Depression: A Cost‐Consequence and Budget Impact Analysis. Journal of Nursing Management (2024).
3. Comparative Effectiveness of a Technology-Facilitated Depression Care Management Model in Safety-Net Primary Care Patients With Type 2 Diabetes: 6-Month Outcomes of a Large Clinical Trial. Journal of Medical Internet Research (2018).
4. Diabetes, minor depression and health care utilization and expenditures: a retrospective database study. Cost Effectiveness and Resource Allocation (2007).